Eldecalcitol: newly developed active vitamin D₃ analog for the treatment of osteoporosis

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.6, 2013-04, pp. : 817-825

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

D-Hormone Derivatives for the Treatment of Osteoporosis: From Alfacalcidol to Eldecalcitol

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 12, 2009-01 ,pp. : 1416-1422

Bentham Science Publishers

Access to resources Recommend Favorite

Eldecalcitol: A Review of its Use in the Treatment of Osteoporosis

By Sanford Mark McCormack Paul L.

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1755-1770

Adis International

Access to resources Recommend Favorite

Chronotherapy with active vitamin D3 in aged stroke-prone spontaneously hypertensive rats, a model of osteoporosis

By Tsuruoka S. Nishiki K. Sugimoto K.-i. Fujimura A.

European Journal of Pharmacology, Vol. 428, Iss. 2, 2001-10 ,pp. : 287-293

Elsevier

Access to resources Recommend Favorite

Calcium Citrate and Vitamin D in the Treatment of Osteoporosis

By Gómez José Manuel Quesada

Clinical Drug Investigation, Vol. 31, Iss. 5, 2011-05 ,pp. : 285-298

Adis International

Access to resources Recommend Favorite

Optimal Vitamin D Status for the Prevention and Treatment of Osteoporosis

By Holick Michael F.

Drugs & Aging, Vol. 24, Iss. 12, 2007-01 ,pp. : 1017-1029

Adis International

Access to resources Recommend Favorite